Andrew Caldwell explains why he decided to participate in an “intimidating” HIV cure study, and how his life changed as a result.
Cirrus embarks on a two-year HIV prevention study, along the way mulling over what might be learned—and how his participation makes a difference. Read More
A new study finds that inflammation-related health concerns are more often a cause of death for people with HIV than cardiovascular disease, AIDS-related complications, and non-AIDS cancer. Find out more, including what you can do to reduce your risk. Read More
1.45 million Americans may be at substantial risk for HIV infection, but only 8% are taking PrEP. Women, people of color, and southern regions are underrepresented. Read More
This week, the FDA granted approval of Gilead Science’s single-table combo pill of bictegravir, emtricitabine, and tenofovir alafenamide named Biktarvy. Read More